U.S. Supreme Court Won’t Review $124M Penalty For Risperdal Marketing
WASHINGTON, D.C. — The U.S. Supreme Court on Jan. 11 declined to review a $124 million consumer law civil penalty imposed by South Carolina against the Ortho-McNeil-Janssen Pharmaceuticals Inc. division of...To view the full article, register now.
Already a subscriber? Click here to view full article